AzTrials
AzTrials

Placental Blood DrainageNCT03020355

Comparison of Blood Loss in Using vs Not Using Placental Cord Drainage After Spontaneous Vaginal Delivery

A study testing Placental Blood Drainage and not Placental Blood Drainage in people with Placental Blood Drainage, run by Zeynep Kamil Maternity and Pediatric Research and Training Hospital.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Comparison of effectiveness of placental blood drainage after spontaneous vaginal delivery in decreasing the duration, blood loss,and complications of the third stage, against no drainage of placental blood. Read more about this study

Who is it for?
Ages 15 to 50 years, women onlyHealthy volunteers can take part
Conditions the study is for
Placental Blood Drainage
What is being tested?
Placental Blood Drainage and not Placental Blood Drainage
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
No sites listed yet
Study dates
Feb 2017to Jun 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 50 years
  • Women only
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Singleton pregnancy
  • Vertex presentation
  • Gestational age of 37 weeks (or) more
  • No major medical (or) obstetric complications
  • Spontaneous vaginal delivery

Who cannot join

  • Hb\7 gm/dl
  • History of APH
  • Instrumental delivery
  • Multiple pregnancy
  • Malpresentations
  • Large baby (more than 3.5 kg)
Show all 9Show fewer
  • Polyhydramnios
  • Known coagulations disorders
  • Previous surgeries on the uterus

About this study

Comparison of effectiveness of placental blood drainage after spontaneous vaginal delivery in decreasing the duration, blood loss,and complications of the third stage, against no drainage of placental blood.

Read the detailed description

The patients will prospectively randomized equally into two groups (100 each in the study and control groups).

Group-A (Study group)-Placental blood was drained.

Group-B (Control group)-Placental blood was not drained.

In all the patients detailed medical and obstetric history will taken. In each patient, the pre-delivery pulse rate, blood pressure, and Hb gm% will noted. Immediately after vaginal delivery, after clamping and cutting the cord-the cord will unclamped and the blood will drained until the flow ceased. In the control group, the clamped cord will not released. Blood lost in the third stage of labour will measured by collecting the blood measuring bag.

Being tested
Placental Blood Drainage, not Placental Blood Drainage

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Placental Blood DrainageProcedure or surgery

    Immediately after vaginal delivery, after clamping and cutting the cord-the cord will unclamped and the blood will drained until the flow ceased.

  • not Placental Blood DrainageProcedure or surgery

    In the control group, the clamped cord will not released.

Study groups in NCT03020355
Study groupRoleWhat they receive
Placental Blood DrainageExperimentalImmediately after vaginal delivery, after clamping and cutting the cord-the cord will unclamped and the blood will drained until the flow ceased.
Receives: Procedure: Placental Blood Drainage
not Placental Blood DrainageActive comparatorIn the control group, the clamped cord will not released.
Receives: Procedure: not Placental Blood Drainage

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Blood lost

    Measured: through delivery completion, an average of 30 minutes

Secondary outcomes (1)
  1. The duration of the third stage

    The duration of the third stage will calculated using a stop watch.

    Measured: through the duration of the third stage, an average 45 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jan 2017 (estimated)
  2. Study startFeb 2017
  3. Primary completionMay 2017 (estimated)
  4. Study completionJun 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03020355
Sponsor's protocol ID
167
Status last verified
Jan 2017
First submitted
22 Dec 2016
Last updated
13 Jan 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
Yes

Publications

  • Roy P, Sujatha MS, Bhandiwad A, Biswas B, Chatterjee A. Placental Blood Drainage as a Part of Active Management of Third Stage of Labour After Spontaneous Vaginal Delivery. J Obstet Gynaecol India. 2016 Oct;66(Suppl 1):242-5. doi: 10.1007/s13224-016-0857-3. Epub 2016 Mar 12.

    PubMed 27651611
  • Soltani H, Poulose TA, Hutchon DR. Placental cord drainage after vaginal delivery as part of the management of the third stage of labour. Cochrane Database Syst Rev. 2011 Sep 7;2011(9):CD004665. doi: 10.1002/14651858.CD004665.pub3.

    PubMed 21901693

Questions about this trial

What is this clinical trial studying?

A study testing Placental Blood Drainage and not Placental Blood Drainage in people with Placental Blood Drainage, run by Zeynep Kamil Maternity and Pediatric Research and Training Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Jan 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Blood lost (time frame: through delivery completion, an average of 30 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03020355, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jan 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in